PMGC Holdings Inc. has acquired common shares in Orbit2Orbit, an Australian company specializing in space logistics and infrastructure, as part of Orbit2Orbit's private placement ahead of its planned Canadian stock exchange listing via reverse takeover. This investment aligns with PMGC's strategy to expand in the growing commercial space sector and complement its U.S. precision manufacturing operations serving aerospace and defense clients. Orbit2Orbit aims to develop in-space logistics services including payload transport and refueling in Low Earth Orbit, addressing a key gap in space infrastructure. PMGC plans to continue enhancing its manufacturing capabilities to support increasing demand for spacecraft components driven by growth in space activities.
PMGC Holdings Inc. share acquisition in Orbit2Orbit provides context for industrial sector activity on Pluang. For readers following Industrials, here is Pluang's market snapshot as of Nov 10, 2026 18:42 WIB: Out of 135 priced US Industrials stocks, 50 rose and 69 fell. Notable movers include LUNR at USD 11.86 with a 1-day change of -1.50% and 82% buy order activity, FLNC at USD 5.48 up 1.48%, and DHT at USD 20.25 down 1.46% with 100% buy order activity.
The 2026 Verizon Data Breach Investigations Report links 61% of manufacturing breaches to third parties and 81% to internal data compromise. Manufacturers adopting Microsoft 365 Copilot should carefully manage which engineering and supplier files emp...
Soleo Health has been selected as a specialty pharmacy partner for Pasatru™ (garetosmab-grts), Regeneron's FDA-approved treatment for adults with fibrodysplasia ossificans progressiva (FOP), an ultra-rare genetic disorder. Pasatru™ is the first treat...
PsiThera raised $25 million in financing led by new investors AbbVie Ventures and Lumination Capital, alongside existing backers. The funds will support development of its oral small molecule TNFα inhibitor and advance its oral TL1A inhibitors into l...
Opus Genetics announced its Q3 2026 financial results and significant progress in its gene therapy programs for inherited retinal diseases. Key milestones include completion of dosing in OPGx-BEST1 Cohort 2 with data expected in Q1 2027, full enrollm...
Iveco Group is exhibiting its latest products, including new light and heavy-duty vehicles powered by FPT engines, at Fenatran 2026 in São Paulo, highlighting its strong industrial and commercial presence in Latin America. The event marks the regiona...
